Wednesday, 28 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Acquisition

Hemant Surgical Industries Acquisition

Hemant Surgical Industries completed the acquisition of Lifesenz Cancer Research Labs Private Limited. The target entity officially became a subsidiary effective June 01, 2026.

Source

BSE filing, BSE: 543916. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Hemant Surgical Industries Ltd: key numbers

Share price
₹572.55
Market cap
₹746.5 Cr
Revenue (annual)
₹231.8 Cr
Net profit (annual)
₹18.19 Cr
P/E (TTM)
41.0×Sector 52.0×
Promoter holding
52.83%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Hemant Surgical Industries Ltd

All →

Other acquisition announcements

All →